Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge

Completed · Phase 4

Conditions studied: Asthma, Pediatric ALL

In brief

This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patients will receive standard card alone.

Key facts

Study ID

NCT03369847

Run by

New York City Health and Hospitals Corporation

People needed

43

Starts

2017-09-10

Expected to finish

2019-06-30

Last updated by the study team

2019-07-18

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Chief complaint consistent with asthma exacerbation
• Previous diagnosis of asthma by a physician OR one major in the Asthma Predictive Index (API) with two prior episodes of wheezing in the past year.
• Major criteria in the API: parent with asthma, patient with eczema, evidence of sensitization to allergens in the air
• Received oral corticosteroids as part of treatment during this visit for acute asthma exacerbation.
• Deemed well enough after interventions to be discharged by the treating physician.
• If <5 years of age, possession of nebulizer machine at home.

You may not qualify if…

• Received asthma controller medications within four weeks prior to presentation
• Allergy to intervention asthma controller medications.

Where it is running

• Kings County Hospital Center — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.